IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
about
Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell CarcinomaDendritic cell immunotherapy in uterine cancer.Prothymosin α and a prothymosin α-derived peptide enhance T(H)1-type immune responses against defined HER-2/neu epitopes.Wilms' tumor gene 1 immunotherapy in pelvic gynecological malignancies.Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.Therapeutic vaccines for high-risk HPV-associated diseases.Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen.IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.
P2860
Q27307719-D77D061F-2B17-4E8C-B773-4C6D54C184B7Q28071998-6BE28CA9-7086-4880-AF7A-2F4D5B3DB3F9Q34291122-766E7E19-9DF1-464E-8BB8-26CA22C99B2DQ34993170-6136BFE2-B003-4620-9660-A56AF0E1222DQ38208388-AB2E9781-57F2-43B1-9EEC-AED558E3EAB7Q42415554-5F17B86C-0B7B-4ADF-A994-E3737764E9AEQ47255618-A363AC9B-BBE0-4B8A-92AF-A8885DD50834Q51063063-C7DBF223-63D4-410A-AC11-1D6436BF761CQ55293126-5D8340A4-E955-4635-9300-82FCEBE92A76Q55515909-102B4BEF-BAC2-4553-B9B4-FC9976449391
P2860
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
@ast
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
@en
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
@nl
type
label
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
@ast
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
@en
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
@nl
prefLabel
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
@ast
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
@en
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
@nl
P2093
P2860
P1433
P1476
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
@en
P2093
Bastian Schilling
James Egan
Malgorzata Harasymczuk
Patrick Schuler
Soldano Ferrone
Theresa L Whiteside
P2860
P304
P356
10.1371/JOURNAL.PONE.0047234
P407
P577
2013-02-07T00:00:00Z